Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A regulatory role for 1-acylglycerol-3-phosphate-O-acyltransferase 2 in adipocyte differentiation.

The Journal of biological chemistry - 21 Apr 2006

Gale Sarah E, Frolov Andrey, Han Xianlin, Bickel Perry E, Cao Li, Bowcock Anne, Schaffer Jean E, Ory Daniel S

Abstract excerpt

Mutations in the 1-acylglycerol-3-phosphate-O-acyltransferase 2 (AGPAT2) gene have been identified in individuals affected with congenital generalized lipodystrophy (CGL). AGPAT2 catalyzes acylation of lysophosphatidic acid to phosphatidic acid, a precursor for both triacylglycerol (TAG) and phos...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 1-Acylglycerol-3-Phosphate O-Acyltransferase
Share to Acyltransferases
Share to Adipocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endoplasmic Reticulum

Share to Intracellular Membranes

Share to Lipodystrophy

Share to Phospholipids

Share to Spectrometry, Mass, Electrospray Ionization

Source

Identifiers

PMID: 16495223
DOI: 10.1074/jbc.M509612200

Genes

AGPAT2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-16495223-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A regulatory role for 1-acylglycerol-3-phosphate-O-acyltransferase 2 in adipocyte differentiation.PMID 16495223Read ↗

AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.Semantic proximity Read ↗

The Role of the AGPAT2 Gene in Adipose Tissue Biology and Congenital Generalized Lipodystrophy PathophysiologySemantic proximity Read ↗

Enzymatic activity of naturally occurring 1-acylglycerol-3-phosphate-O-acyltransferase 2 mutants associated with congenital generalized lipodystrophy.Semantic proximity Read ↗

AGPAT3 deficiency impairs adipocyte differentiation and leads to a lean phenotype in mice.Semantic proximity Read ↗

Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways.Semantic proximity Read ↗

Expression of AGPAT2, an enzyme involved in the glycerophospholipid/triacylglycerol biosynthesis pathway, is directly regulated by HIF-1 and promotes survival and etoposide resistance of cancer cells under hypoxia.Semantic proximity Read ↗

Genetic basis of congenital generalized lipodystrophy.Semantic proximity Read ↗

Loss of adipocyte phospholipase gene <i>PLAAT3</i> causes lipodystrophy and insulin resistance due to inactivated arachidonic acid-mediated PPAR <i>γ</i> signalingSemantic proximity Read ↗

Oligomers of the lipodystrophy protein seipin may co-ordinate GPAT3 and AGPAT2 enzymes to facilitate adipocyte differentiation.Semantic proximity Read ↗

The Human Lipodystrophy Gene BSCL2/Seipin May Be Essential for Normal Adipocyte DifferentiationSemantic proximity Read ↗

The lipin family: mutations and metabolism.Semantic proximity Read ↗

Genetics of Lipodystrophy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.